Oral Care Compositions and Methods of Use
US-2017367939-A1 · Dec 28, 2017 · US
US10555883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10555883-B2 |
| Application number | US-201615548857-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 24, 2016 |
| Priority date | Jul 1, 2015 |
| Publication date | Feb 11, 2020 |
| Grant date | Feb 11, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to oral care compositions comprising a basic amino acid in free or salt from (e.g., free form arginine); zinc oxide and zinc citrate; and a fluoride source comprising stannous fluoride.
Opening claim text (preview).
What is claimed is: 1. An oral care composition comprising: a. a basic amino acid in free or salt form, wherein the amino acid is L-arginine in an amount of about 1.5 wt. %; b. zinc oxide and zinc citrate, wherein the zinc citrate is in an amount of about 0.5 wt. % and zinc oxide may be present in an amount of about 1.0 wt. % based on the total weight of the composition; c. a fluoride source comprising stannous fluoride, wherein the stannous fluoride is present in an amount from 0.1 wt. % to 2 wt. % based on the total weight of the composition, and wherein the stannous fluoride provides about 750-7000 ppm fluoride; and d. about 5% small particle silica, based on the total weight of the composition. 2. The oral care composition of claim 1 wherein the amino acid is arginine in free form. 3. The oral care composition of claim 1 wherein the amino acid is arginine partially or wholly in salt form. 4. The oral care composition of claim 1 , wherein the fluoride source further comprises at least one member selected from the group of: sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride (e.g., N′-octadecyltrimethylendiamine-N,N,N′-tris(2-ethanol)-dihydrofluoride), ammonium fluoride, titanium fluoride, hexafluorosulfate, and combinations thereof. 5. The composition of claim 1 , wherein stannous fluoride provides soluble fluoride in an amount of about 1000-5500 ppm. 6. The composition of claim 1 , wherein stannous fluoride provides soluble fluoride in an amount of about 5000 ppm. 7. The oral care composition of claim 1 further comprising: d. about 39.2% glycerin based on the total weight of the composition. 8. The oral care composition of claim 1 , wherein the oral composition may be any of the following oral compositions selected from the group consisting of: a toothpaste or a dentifrice, a mouthwash or a mouth rinse, a topical oral gel, and a denture cleanser.
Local antiseptics · CPC title
Antibacterial agents · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.